131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol
NCT01163383
·
clinicaltrials.gov ↗
AVAILABLE
Status
OTHER
Sponsor class
Conditions
Neuroblastoma
Childhood Metastatic Pheochromocytoma
Interventions
DRUG:
131 I-Metaiodobenzylguanidine (131 I-MIBG)
DRUG:
131 I-MIBG
Sponsor
John Maris